Assays for Hypercoagulability

  • Robert D. Rosenberg
  • Herbert Lau
  • David Beeler
  • Judith S. Rosenberg
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 104)


Many investigators have attempted to determine whether a relationship exists between excessive activity of the hemostatic mechanism and the atherosclerotic process. A major difficulty encountered in unraveling this puzzle has been the lack of reliable techniques for quantifying pertinent changes in blood coagulability. We have focused our attention on detecting alterations in the zymogens and protease inhibitors of the coagulation system which might occur prior to the development of overt thrombotic phenomena. Measurement of these early changes may be critical, if we wish to dissect the molecular events which are ultimately responsible for the atherosclerotic lesion and intervene with appropriate therapy prior to the onset of gross pathologic changes. In the sections below, we outline the difficulties associated with developing this methodology. Furthermore, we describe two new radioimmunoassays that may serve as prototype techniques for monitoring the activity of the hemostatic mechanism.


Thrombin Generation Coagulation System Antibody Preparation Activation Fragment Displacement Point 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rosenberg, J.S., Beeler, D.F., and Rosenberg, R.D. (1975) J. Biol. Chem. 250, 1607–1617.PubMedGoogle Scholar
  2. 2.
    Kisiel, W., and Hanahan, D.J. (1973) Biophys. Acta 329, 221–232.CrossRefGoogle Scholar
  3. 3.
    Stenn, K., Blout, E.R. (1972) Biochemistry 11, 4502–4515.PubMedCrossRefGoogle Scholar
  4. 4.
    Esmon, C.T., Owen, W.G., Jackson, C.M. (1974) J. Biol. Chem. 249, 594.PubMedGoogle Scholar
  5. 5.
    Bajaj, S.P., Butkowski, R.J., and Mann, K.G. (1975) J. Biol. Chem. 250, 2150–2156.PubMedGoogle Scholar
  6. 6.
    Downing, M.R., Butkowski, R.J., Clark, M.M., Mann, K.G. (1975) J. Biol. Chem. 250, 8897.PubMedGoogle Scholar
  7. 7.
    Waugh, D.F., Fitzgerald, M.A. (1956) Am. J. Physiol. 184, 627639.Google Scholar
  8. 8.
    Janoff, A. (1972) Am. Rev. Respir. Dis. 105, 121–122.PubMedGoogle Scholar
  9. 9.
    Schultze, H.E., Glollner, I., Heide, K., et al. (1955) Z Naturforsch (B) 10, 463–473.Google Scholar
  10. 10.
    Donaldson, V.H., and Evans, R.R. (1963) Am. J. Med. 35, 37–44.PubMedCrossRefGoogle Scholar
  11. 11.
    Eriksson, S. (1965) Acta Med. Scand. 177 (Suppl. 432), 1–85.Google Scholar
  12. 12.
    Rosenberg, R.D., and Damus, P.S. (1973) J. Biol. Chem. 238, 7149–7163.Google Scholar
  13. 13.
    Rosenberg, J.S., McKenna, P.W., Rosenberg, R.D. (1975) J. Biol. Chem. 250, 8883–8888.PubMedGoogle Scholar
  14. 14.
    Kurachi, K., Fujikawa, K., Schmier, G., and Davie, E.W. (1976) Biochem. 15, 373–377.CrossRefGoogle Scholar
  15. 15.
    Damus, P.S., Hicks, M., and Rosenberg, R.D. (1973) Nature 246, 355–357.PubMedCrossRefGoogle Scholar
  16. 16.
    Stead, N.W., Kaplan, A., and Rosenberg, R.D. (1976) J. Biol. Chem. 251, 6481–6488.PubMedGoogle Scholar
  17. 17.
    Egeberg, O. (1965) Thromb. Diath. and Haemorrh. 13, 516–530.Google Scholar
  18. 18.
    Aronson, D.L. (1975) J. Biol. Chem. 250, 7057.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Robert D. Rosenberg
    • 1
  • Herbert Lau
    • 1
  • David Beeler
    • 1
  • Judith S. Rosenberg
    • 1
  1. 1.Department of Medicine of Beth Israel Hospital Sidney Farber Cancer ClinicHarvard Medical SchoolBostonUSA

Personalised recommendations